Kyoto, Japan

Wakao Iwatani

This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wakao Iwatani. Retrieved from https://idiyas.com/inventor/wakao-iwatani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Wakao Iwatani

Introduction

Wakao Iwatani is a notable inventor based in Kyoto, Japan, recognized for his contributions to the field of pharmaceuticals through innovative chemical compounds. With a focus on oxime derivatives, his work emphasizes the importance of structural diversity in drug design.

Latest Patents

Iwatani holds a significant patent for oxime derivatives, which are characterized by a complex formula. This invention includes various functional groups, showcasing versatility where R can be a hydrogen atom or a C1-5 alkyl group, and other components allowing for modifications. The compound holds potential for pharmaceutical applications, possibly leading to advancements in medical therapies.

Career Highlights

Currently, Wakao Iwatani is employed at Kaken Pharmaceutical Company, Ltd., where he contributes to research and development efforts. His career at Kaken has been marked by a commitment to advancing pharmaceutical chemistry and innovation.

Collaborations

Throughout his career, Iwatani has collaborated with esteemed colleagues, including Jun Nakano and Hideto Fukui. These partnerships have fostered a creative and productive environment, furthering the scope of their research in medicinal chemistry.

Conclusion

Wakao Iwatani's inventive spirit and contributions through his patent on oxime derivatives highlight his role in the pharmaceutical industry. His ongoing work at Kaken Pharmaceutical Company, along with collaborations with talented professionals, positions him as a key figure in the pursuit of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…